Use access key #2 to skip to page content.

manirg (68.78)

Gilead Sovaldi Sales

Recs

4

January 25, 2014 – Comments (6) | RELATED TICKERS: GILD

Analysts' estimate for Sovaldi sales is very conservative. Sovaldi TRx for the 6th week is about 2500. So if I usethis figure I get 2500x50(wks)x$60,000( discounted price/patient)=$7.5B for this year. But this does not includeany sales for Europe etc. which is even a bigger market than U.S. Also, this is only 6th week after its launch andthe TRx could get to 4000-5000 per week. Thus I would say Sovaldi sales could exceed $15B easily. Am I missingsomething or the Wall Street is totally wrong? 

 

6 Comments – Post Your Own

#1) On January 25, 2014 at 10:41 PM, portefeuille (99.61) wrote:

TRx = Total Prescriptions, NRx = New Prescriptions.

https://twitter.com/H3NPHLO/statuses/426720415210143744

https://twitter.com/chasingthealpha/statuses/425092115312300032

http://www.thestreet.com/story/12253453/1/gileads-sovaldi-hep-c-drug-launch-strong.html

https://twitter.com/MarkSchoenebaum/statuses/426695903219441664

 

https://twitter.com/portefeuillefun

https://twitter.com/search?q=%23zzporte&src=hash&f=realtime

;)

Report this comment
#2) On January 25, 2014 at 11:30 PM, portefeuille (99.61) wrote:

An attempt to estimate the revenue potential of GILD is a good topic for a first blog post BTW, you just may have chosen a dying platform, so if you have not done so already you might want to establish a twitter presence :)

Report this comment
#3) On January 31, 2014 at 9:31 AM, Mary953 (77.79) wrote:

Porte, you did not just tell manirg to stop posting on CAPS and go post on Twitter instead...Tell me I am wrong about that, please!

Manirg, if you want to discuss biopharma, then Porte is the one you want to be talking to.  He does comment on the CAPS blogs that interest him and I do try to jump in and welcome first time posters.  If you will check this out, it may give you a look at the various ways people interact here.  http://caps.fool.com/Blogs/some-posts-to-get-you-started/924156#commentsForm  And Porte, please pick your latest and greatest blog to add to the index there.  I was not sure which one you would want listed but you always have the best biopharma advice. 

Report this comment
#4) On February 01, 2014 at 7:28 AM, GirlsUnder30 (93.97) wrote:

Mary953

Nice to see you actively posting, how's everyone at the senior gym? I don't think portefeuille should be admonished for salting his opinion with a little humor. We fools need to have a thicker skin. Those looking for a healthcare play should read:

http://caps.fool.com/Blogs/pozn-for-a-headache/911504

Report this comment
#5) On February 01, 2014 at 10:53 AM, Mary953 (77.79) wrote:

At the gym, I am frequently mistaken for someone in her 40's which is down right necessary.  Yesterday I exercised with a dear lady in her early 70's (she was 84) and a lady in her 60's (72).  Same thing with a lot of the guys - including my husband.  It is amazing what exercise can do for you.

Porte is fantastic, and I may have misunderstood one of his remarks.  So long as the "dying platform" is not CAPS, then I owe him an apology.  He will be the reason I end up with a Twitter account eventually, I suspect.

I love POZN.  I have made a bunch of money off of the stock and cannot wait to get prescriptions from them (I am allergic to NSAIDS)  Would you please go to the blog that I referenced and add your blog in the comments?  It is the type of thing that needs to be there. 

Report this comment
#6) On February 01, 2014 at 3:50 PM, GirlsUnder30 (93.97) wrote:

Mary953
I did as you requested. 

Report this comment

Blog Archive

2014
January (1)

Featured Broker Partners


Advertisement